Pubblicazioni scientifiche

Fontana L; Moramarco A; Mandarà E; Russello G; Iovieno A, Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review, «BRITISH JOURNAL OF OPHTHALMOLOGY», 2019, 103, pp. 307 - 314 [Articolo in rivista]

Lewis R.E.; Kontoyiannis D.P.; Viale P.; Sarpong E.M., Using state transition models to explore how the prevalence of subtherapeutic posaconazole exposures impacts the clinical utility of therapeutic drug monitoring for posaconazole tablets and oral suspension, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2019, 63, pp. 1 - 12 [Articolo in rivista]

Bartoletti M.; Giannella M.; Lewis R.E.; Caraceni P.; Tedeschi S.; Paul M.; Schramm C.; Bruns T.; Merli M.; Cobos-Trigueros N.; Seminari E.; Retamar P.; Munoz P.; Tumbarello M.; Burra P.; Cerenzia M.T.; Barsic B.; Calbo E.; Maraolo A.E.; Petrosillo N.; Galan-Ladero M.A.; D'Offizi G.; Zak-Doron Y.; Rodriguez-Bano J.; Baldassarre M.; Verucchi G.; Domenicali M.; Bernardi M.; Viale P., Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study, «CLINICAL INFECTIOUS DISEASES», 2019, 69, pp. 1731 - 1739 [Articolo in rivista]

Quaglino P.; Maule M.; Prince H.M.; Porcu P.; Horwitz S.; Duvic M.; Talpur R.; Vermeer M.; Bagot M.; Guitart J.; Papadavid E.; Sanches J.A.; Hodak E.; Sugaya M.; Berti E.; Ortiz-Romero P.; Pimpinelli N.; Servitje O.; Pileri A.; Zinzani P.L.; Estrach T.; Knobler R.; Stadler R.; Fierro M.T.; Alberti Violetti S.; Amitay-Laish I.; Antoniou C.; Astrua C.; Chaganti S.; Child F.; Combalia A.; Fabbro S.; Fava P.; Grandi V.; Jonak C.; Martinez-Escala E.; Kheterpal M.; Kim E.J.; McCormack C.; Miyagaki T.; Miyashiro D.; Morris S.; Muniesa C.; Nikolaou V.; Ognibene G.; Onida F.; Osella-Abate S.; Porkert S.; Postigo-Llorente C.; Ram-Wolff C.; Ribero S.; Rogers K.; Sanlorenzo M.; Stranzenbach R.; Spaccarelli N.; Stevens A.; Zugna D.; Rook A.H.; Geskin L.J.; Willemze R.; Whittaker S.; Hoppe R.; Scarisbrick J.; Kim Y., Corrigendum: Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (Annals of Oncology (2017) 28 (2517-2525) DOI: 10.1093/annonc/mdx352), «ANNALS OF ONCOLOGY», 2019, 30, pp. 494 - 494 [Articolo in rivista]

Ciavarella S.; Vegliante M.C.; Fabbri M.; De Summa S.; Melle F.; Motta G.; De Iuliis V.; Opinto G.; Enjuanes A.; Rega S.; Gulino A.; Agostinelli C.; Scattone A.; Tommasi S.; Mangia A.; Mele F.; Simone G.; Zito A.F.; Ingravallo G.; Vitolo U.; Chiappella A.; Tarella C.; Gianni A.M.; Rambaldi A.; Zinzani P.L.; Casadei B.; Derenzini E.; Loseto G.; Pileri A.; Tabanelli V.; Fiori S.; Rivas-Delgado A.; Lopez-Guillermo A.; Venesio T.; Sapino A.; Campo E.; Tripodo C.; Guarini A.; Pileri S.A., Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450), «ANNALS OF ONCOLOGY», 2019, 29, pp. 2363 - 2370 [Articolo in rivista]

Massari F.; Di Nunno V.; Mollica V.; Graham J.; Gatto L.; Heng D., Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta-Analysis of Available Clinical Trials, «CLINICAL GENITOURINARY CANCER», 2019, 17, pp. 339 - 344 [Articolo in rivista]

Massari F.; Di Nunno V.; Santoni M., Re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. N Engl J Med 2018;379:417–27: CARMENA Trial: Is This the End of Cytoreductive Nephrectomy in Patients with Clear-cell Renal Cell Carcinoma?, «EUROPEAN UROLOGY ONCOLOGY», 2019, 2, pp. 340 - 341 [Articolo in rivista]

Santoni M.; Conti A.; Massari F.; Di Nunno V.; Faloppi L.; Galizia E.; Morbiducci J.; Piva F.; Buti S.; Iacovelli R.; Ferretti B.; Cimadamore A.; Scarpelli M.; Lopez-Beltran A.; Cheng L.; Battelli N.; Montironi R., Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies, «EXPERT REVIEW OF CARDIOVASCULAR THERAPY», 2019, 17, pp. 917 - 927 [Articolo in rivista]

Prisciandaro M.; Ratta R.; Massari F.; Fornarini G.; Caponnetto S.; Iacovelli R.; De Giorgi U.; Facchini G.; Scagliarini S.; Sabbatini R.; Caserta C.; Peverelli G.; Mennitto A.; Verzoni E.; Procopio G., Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program, «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2019, 42, pp. 42 - 45 [Articolo in rivista]

Cimadamore A.; Santoni M.; Massari F.; Gasparrini S.; Cheng L.; Lopez-Beltran A.; Montironi R.; Scarpelli M., Microbiome and cancers, with focus on genitourinary tumors, «FRONTIERS IN ONCOLOGY», 2019, 9, pp. 1 - 6 [Articolo in rivista] Open Access

Cimadamore A.; Scarpelli M.; Santoni M.; Massari F.; Tartari F.; Cerqueti R.; Lopez-Beltran A.; Cheng L.; Montironi R., Genitourinary tumors: Update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy, «CURRENT DRUG METABOLISM», 2019, 20, pp. 305 - 312 [Articolo in rivista]

Mollica V.; Di Nunno V.; Massari F., Pembrolizumab plus axitinib: A new treatment option for patients with metastatic renal cell carcinoma, «CHINESE CLINICAL ONCOLOGY», 2019, 8, pp. 1 - 4 [Articolo in rivista]

Santoni M.; Cimadamore A.; Massari F.; Piva F.; Aurilio G.; Martignetti A.; Scarpelli M.; Di Nunno V.; Gatto L.; Battelli N.; Cheng L.; Lopez-Beltran A.; Montironi R., Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers, «CANCERS», 2019, 11, pp. 1 - 16 [Articolo in rivista] Open Access

Di Nunno V.; Mollica V.; Massari F., N-Myc a key gene promoting a worst prostate cancer progression, «TRANSLATIONAL CANCER RESEARCH», 2019, 8, pp. 15 - 17 [Articolo in rivista]

Massari F.; Di Nunno V.; Santoni M.; Gatto L.; Caserta C.; Morelli F.; Zafarana E.; Carrozza F.; Mosca A.; Mollica V.; Iacovelli R.; Sabbatini R.; Porta C.; Bracarda S., Toward a genome-based treatment landscape for renal cell carcinoma, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2019, 142, pp. 141 - 152 [Articolo in rivista]

Saeed O.; Lopez-Beltran A.; Fisher K.W.; Scarpelli M.; Montironi R.; Cimadamore A.; Massari F.; Santoni M.; Cheng L., RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications, «JOURNAL OF CLINICAL PATHOLOGY», 2019, 72, pp. 135 - 139 [Articolo in rivista]

Di Nunno V.; Santoni M.; Massari F., New Hormonal Agents in Patients with Nonmetastatic Castration-resistant Prostate Cancer: Can We Be Satisfied with an Advantage in Metastasis-free Survival?, «EUROPEAN UROLOGY ONCOLOGY», 2019, 2, pp. 471 - 471 [Articolo in rivista]

Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Battelli N.; Montironi R.; Massari F., Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor, «CANCERS», 2019, 11, pp. 1 - 16 [Articolo in rivista] Open Access

Massari F.; Di Nunno V.; Santoni M.; Gatto L.; Mollica V.; Porta C., Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End, «EUROPEAN UROLOGY ONCOLOGY», 2019, 2, pp. 603 - 604 [Articolo in rivista]

Gasparrini S.; Cimadamore A.; Scarpelli M.; Massari F.; Doria A.; Mazzucchelli R.; Cheng L.; Lopez-Beltran A.; Montironi R., Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians, «ASIAN JOURNAL OF ANDROLOGY», 2019, 21, pp. 19 - 23 [Articolo in rivista] Open Access